PRAC recommendations on signals adopted at the 27-30 October 2025 PRAC meeting

PSUSA/00003045/202501

Organisation Management Service (OMS)

Referentials Management Service (RMS)

Vaccines: concerns, questions and false claims

Human medicines European public assessment report (EPAR): Steglujan, ertugliflozin,sitagliptin, Date of authorisation: 23/03/2018, Revision: 14, Status: Authorised

Human medicines European public assessment report (EPAR): Segluromet, ertugliflozin,metformin hydrochloride, Date of authorisation: 23/03/2018, Revision: 10, Status: Authorised

Human medicines European public assessment report (EPAR): Invanz, ertapenem, Date of authorisation: 18/04/2002, Revision: 29, Status: Authorised

Human medicines European public assessment report (EPAR): Obizur, susoctocog alfa, Date of authorisation: 11/11/2015, Revision: 13, Status: Authorised

Human medicines European public assessment report (EPAR): Yervoy, ipilimumab, Date of authorisation: 13/07/2011, Revision: 59, Status: Authorised